Skip to main content

Investors

Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.

About Us

We are technology leaders in distribuited and connected diagnostics


Investors

The Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.


24 September, 2020

Scientific publications

Field-deployable molecular diagnostic platform for arbovirus detection in Aedes aegypti


This study evaluates the performance of the bCUBE system, a compact and portable qPCR platform, as a tool for molecular surveillance of arboviruses directly in the field. By comparing results with those obtained from standard laboratory instrumentation on Aedes aegypti mosquitoes experimentally infected with Zika and Dengue viruses, researchers demonstrated that the device offers high sensitivity and specificity, effectively detecting viral RNA in both single specimens and mosquito pools. The data indicate that this technology represents a reliable and rapid solution for entomological monitoring, enabling the decentralization of diagnostics and supporting vector control strategies in at-risk areas more timely.


Parasites & Vectors | 2025